How biotech giant Bayer landed a win that infuriated MAHA

By Marcia Brown, Cheyenne Haslett | 03/23/2026 11:51 AM EDT

The company says it told the White House that it would take Roundup off the market if it didn’t get reassurances about MAHA’s ire.

Containers of Roundup are displayed on a store shelf in San Francisco.

Containers of Roundup are displayed on a store shelf in San Francisco on Feb. 24, 2019. Haven Daley/AP

Bayer executives had warned for years that the company was on the brink of pulling its weedkiller Roundup from the U.S. market.

But when Health Secretary Robert F. Kennedy Jr. in May released the first Make America Healthy Again report, blaming the chemical for Americans’ health problems in an official government document, the company says it told the Trump administration that the walls were closing in.

Bayer’s CEO met with top White House officials last year and said the company could absorb billions of dollars in litigation costs from lawsuits alleging that glyphosate, the active ingredient in Roundup, caused cancer — but it couldn’t also face down regulatory uncertainty and what executives saw as the prospect of a government ban.

Advertisement

It might leave the U.S. market, it told the White House, taking with it one of the most widely used products on U.S. farmland. For the White House, Bayer’s warning also underscored ongoing concerns about phosphorus, the critical mineral used to make glyphosate, for which Bayer is the sole domestic producer. Phosphorus is also used to make weapons, fertilizer and semiconductors.

GET FULL ACCESS